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Keratoconus (KC) is the most common corneal ectatic disorder affecting >300,000 people in the US. 
KC normally has its onset in adolescence, progressively worsening through the third to fourth decades 
of life. KC patients report significant impaired vision-related quality of life. Genetic factors play an 
important role in KC pathogenesis. To identify novel genes in familial KC patients, we performed whole 
exome and genome sequencing in a four-generation family. We identified potential variants in the 
PPIP5K2 and PCSK1 genes. Using in vitro cellular model and in vivo gene-trap mouse model, we found 
critical evidence to support the role of PPIP5K2 in normal corneal function and KC pathogenesis. The 
gene-trap mouse showed irregular corneal surfaces and pathological corneal thinning resembling 
KC. For the first time, we have integrated corneal tomography and pachymetry mapping into 
characterization of mouse corneal phenotypes which could be widely implemented in basic and 
translational research for KC diagnosis and therapy in the future.
Keratoconus (KC, OMIM 14830) is a bilateral, asymmetric corneal degeneration characterized by localized thin-
ning and protrusion of the thinned cornea, which can lead to high myopia, irregular astigmatism, and cornea 
scarring1,2. It has been reported that genetic, environmental, biomechanical, hormonal, enzymatic, and possi-
bly inflammatory factors contribute to the pathogenesis of KC2–4. Although the majority of KC cases are spo-
radic, the genetic contribution in KC pathogenesis has been validated by various studies5. Familial inheritance 
was reported in 6–23.5% of KC patients, and first-degree relatives are at 15–67 times higher risk than the gen-
eral population6. Familial KC is mostly inherited through autosomal dominant and occasionally recessive pat-
terns6,7. More concordance of KC severity has been reported in monozygotic (MZ) twins than dizygotic twins 
(DZ)5,8,9, and consanguineous marriage (first-cousin marriage) is a risk factor for KC10,11. KC was also reported 
to be associated with chromosomal abnormality disorders such as Down syndrome (trisomy 21) and 22q11.2 
deletion syndrome12–15. Furthermore, KC is associated with multiple genetically inherited disorders including 
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Figure 1. The pedigree structure and the genotypes of identified pathogenic variants in keratoconus-affected 
multiplex families with autosomal dominant inheritance using whole exome and whole genome sequencing. 
(A) The pedigree structure of the four-generation family with keratoconus. Generations are indicated by 
the Roman numbers I, II, III, and IV on the left side. Individuals in each generation are labeled with Arabic 
numbers 1 to 14. Linkage haplotypes are labeled under each individual. The gray haplotype is linked with 
keratoconus. Individuals with dashed lines were not enrolled in the genetic study, while those with the solid 
lines were consented and enrolled. Subjects with a black arrow were selected for whole exome sequencing 
while those with a black circle were selected for whole genome sequencing. (B) The alleles are indicated as 
major allele/minor allele. PPIP5K2 variant rs35471301, p.Ser419Ala, S419A (T/G). Two individuals (III9 and 
IV9) carrying the linkage haplotype indicated by a grey bar are homozygotes for the major allele T. (C) PCSK1 
variant rs373951075 (G/A). All individuals with KC carrying the linkage haplotype indicated by grey bar are 
heterozygous for the minor allele A. (D) The pedigree structure of a second unrelated multiplex family and the 
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Leber congenital amaurosis16,17, cataract18, retinal cone dystrophy19, Ehlers–Danlos syndrome, and osteogenesis 
imperfecta20,21.
Genome-wide linkage analyses have identified a number of genomic loci linked with KC. These include 
1p36.23–36.21, 2p24, 2q13, 3p14-q13, 5q14.3-q21.1, 5q21.2, 5q32-q33, 8q13.1-q21.11, 9q34, 13q32, 14q11.2, 
14q24.3, 15q15.1, 15q22.33–24.2, 16q22.3-q23.1, and 20p13-p12.2, 20q1222. However, the exact disease-causing 
mutations remain unknown for most patients23. Intriguingly, the linkage locus 5q21.2 has been replicated in 
two independent studies24,25. Follow-up studies have identified many potential mutations segregating with 
KC including MIR184 c.57 C > T18,26–32. The mutation MIR184 c.57 C > T was identified in the linkage region 
15q22.32–24.2 in a Northern-Irish family who suffered from KC and congenital cataract through targeted 
sequencing-capture18,33,34. MIR184 c.57 C > T mutation has been functionally validated by an in vitro model18. 
However, in vitro and/or in vivo models are necessary to elucidate the potential molecular impact of identified 
mutations in KC pathogenesis.
Targeted sequencing has been successful in elucidating the causative genetic mutation(s) in numerous inher-
ited diseases such as neurofibromatosis type 1, Marfan syndrome, dilated cardiomyopathy, congenital disorders of 
glycosylation, and KC35,36. However, targeted sequencing relies on the prior identification of a significant linkage 
locus. The advent of whole exome sequencing (WES) or whole genome sequencing (WGS) technology offers a 
significant advantage by interrogating all the coding or genome sequence in the absence of a linkage locus35. WES 
is often used to identify variants in the protein-coding regions (about 1% of human genome), while WGS explores 
variants in the whole genome as well as structural changes such as copy number variants. We have successfully 
used WES and WGS to identify pathogenic variant(s) in a four-generation KC family with a reported linkage 
locus chr5q14.3–21.1 with autosomal dominant inheritance24,37.
Results
Sequence variants identified in the KC family linked to chr5q14.3–21.1. In the four-generation 
multiplex family previously linked to chr5q14.3–21.124,37, we selected ten individuals (KC patients: II5, III4, III5, 
IV4, IV5, IV10, and IV12; controls: III12, III13, and III14) for WES sequencing (Fig. 1A, with selected individuals 
indicated by a black arrow). After no relevant candidate variants were identified in a narrow 95–100 Mb region 
identified by both linkage and association analysis37, we extended the targeted region to cover the original link-
age peak24 and identified a non-synonymous variant rs35671301 (chr5:103,154,707, c. 1255 T > G, p.Ser419Ala, 
S419A) located in the PPIP5K2 (Diphosphoinositol Pentakisphosphate Kinase 2) gene. This is potentially a sig-
nificant observation, as PPIP5K2 is a bi-functional kinase/phosphatase that controls the cell-signaling activities 
of the inositol pyrophosphates, InsP7 (diphosphoinositol pentakisphosphate) and InsP8 (bis-diphosphoinositol 
tetrakisphosphate)38–40. This variant co-segregates with KC in all 10 individuals sequenced with WES in this 
family. This variant was categorized as a rare change with a global MAF (minor allele frequency) of 0.0069 in 
the GnomAD database (genome aggregation database, gnomad.broadinstitute.org). Using PCR-based Sanger 
sequencing, we verified this variant was present in all 10 selected individuals for WES and we confirmed the 
segregation of this variant with KC in all affected individuals carrying the linkage haplotype except individual 
III9 (see grey panels in Fig. 1B, Supplemental Table 1). S419 of PPIP5K2 is highly evolutionally conserved from 
zebrafish to humans (Supplemental Fig. 1), suggesting its potential important function of the PPIP5K2 protein.
We also selected five family members for follow-up analysis with WGS: four KC patients and one control 
(Fig. 1A, III7, IV2, IV5, IV8, and IV10 with a black circle). Using our established variant filtering pipeline41, 
we verified the non-synonymous mutation in the PPIP5K2 gene and identified an additional intronic variant 
rs373951075 (chr5:96,408,333, c.1096–10 G > A, GnomAD MAF 0.00026) in the PCSK1 gene (proprotein con-
vertase subtilisin/kexin type 1). Using PCR-based Sanger sequencing, we verified this PCSK1 variant in all avail-
able family members which showed complete segregation with KC (Fig. 1C, Supplemental Table 1). Analysis of 
evolutional conservation only showed invariant nucleotide G in higher mammals and primates (Supplemental 
Fig. 2). Notably, this variant is located in the ClinVar database with a designation of a variant of unknown signifi-
cance after being identified in patients with proprotein convertase 1/3 deficiency and monogenic non-syndromic 
obesity. It is noted that this variant is not present in the mouse/rat genome.
Sequence variant in PPIP5K2 in a second family with familial KC. Using WES data from a second 
KC-affected family with four selected individuals (Fig. 1D, KC: 301 and 303; controls: 201 and 202, indicated 
by the black arrow), we identified another nonsynonymous variant (rs781831998, c.2528 A > G, p.Asn843Ser, 
N843S) in the PPIP5K2 gene with a global MAF of 0.00006 in the GnomAD database. Using PCR-based Sanger 
sequencing, we successfully verified the mutation and screened for this mutation in other family members 
(Fig. 1D, Supplemental Table 2). The presence of this missense mutation in other unaffected family members 
indicates its incomplete penetrance of this missense mutation, similar to the first mutation identified in the 
four-generation family. Across 100 different vertebrates, the amino acid at this position is either aspartic acid 
(D) or asparagine (N) (Supplemental Fig. 3). The rare change to serine at this position could impact the protein 
function of PPIP5K2. Interestingly, both S419A and N843S mutations are located in the phosphatase domain 
(amino acids 363–909) of the PPIP5K2 protein and could impact the dynamic balance of phosphatase and kinase 
activities (Fig. 2A). Therefore, we focused our research on the potential role of PPIP5K2 variants in the patho-
genesis of KC.
genotypes of a pathogenic variant in the PPIP5K2 gene. Subjects with a black arrow were selected for whole 
exome sequencing and bioinformatics analysis. Additional individuals were analyzed by PCR-based Sanger 
sequencing. Allele G is the minor allele.
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Biochemical properties of PPIP5K2 protein carrying the two identified variants. To determine 
the biochemical effects of both nonsynonymous variants on the PPIP5K2 protein, we used HEK cells as a host for 
heterologous expression of either wild-type PPIP5K2 protein or each of the S419A or N843S variants; the addi-
tion of an N-terminal FLAG tag (FLAG octapeptide or epitope with the sequence DYKDDDDK) assisted protein 
purification for in vitro measurements of the separate kinase and phosphatase activities42. These enzymatic assays 
(n = 4) showed that the N843S variant caused a significant 15% reduction in the PPIP5K2 phosphatase activity 
(p < 0.05), while the S419A variant did not change the phosphatase activity significantly (p > 0.05) (Fig. 2B). 
Both variants separately exhibited elevated kinase activities in vitro, although this was only statistically signifi-
cant for the N843S mutation (Fig. 2C). These in vitro biochemical assays provide direct evidence that the N843S 
variant alters the catalytic functions of PPIP5K2. Because of the “futile-cycle” catalyzed by the PPIP5K protein 
(Fig. 2A), the two separate but reciprocal effects of the N843S variant (inhibition of phosphatase and activa-
tion of kinase) can be expected to produce a synergistic enhancement of InsP8 synthesis in vivo40,43. The signif-
icance of S419 to PPIP5K2 functionality remains to be determined; perhaps it has a regulatory role by being a 
target for covalent modification. This residue lies 25 residues outside the catalytic RHGDRTP motif, within a 
polyphosphoinositide-binding module44.
Expression of PPIP5K2 in human and mouse ocular tissue and cells. We used ddPCR (droplet 
digital PCR) assays to examine the expression of PPIP5K2 and its paralog PPIP5K1 in primary human corneal 
epithelial cells (HCEC) (n = 3), and also in primary human corneal stromal fibroblast (HCSF) cells (n = 3). We 
found that PPIP5K2 mRNA showed 5-fold higher expression than PPIP5K1 mRNA in human HCEC and HCSF 
cells (Fig. 3A). Immunofluorescence staining in human and mouse corneas and mouse retinas demonstrated 
an exclusive high expression of PPIP5K2 protein in both human (Fig. 3B,C) and mouse corneas (Fig. 3D,E), 
while PPIP5K1 showed higher expression in mouse retina (Fig. 3F,G). The unique expression of PPIP5K2 but 
not PPIP5K1 in human and mouse corneas confirms the potential functional significance of PPIP5K2 in corneal 
physiological processes.
Corneal pathological phenotypes in Ppip5k2+/K^ & Ppip5k2K^/K^ mouse model. In order to model 
the elevated kinase and reduced phosphatase activity in PPIP5K2, we obtained a Ppip5k2-gene-trap mouse 
B6N(Cg)-Ppip5k2tm1b(EUCOMM)Wtsi/J from the Jackson Laboratory. A beta-galactosidase containing cassette with an 
Figure 2. Schematic diagram of PPIP5K1 and PPIP5K2 domains and the in vitro biochemical assays for the 
phosphate and the kinase activities carrying the identified pathogenic variants. (A) Diagram of PPIP5K1 and 
PPIP5K2 functional domains with the identified pathogenic variants. The text with arrows shows our identified 
pathogenic variants located in the phosphatase domain of PPIP5K2. (B) PPIP5K2-phosphatase activity 
level with the two identified variants. (C) PPIP5K2-kinase activity level with the two identified variants. K2 
represents hsa-PPIP5K2, K2S419A represents hsa-PPIP5K2 with Serine 419 to Alanine change, and K2N843S 
represents hsa-PPIP5K2 with Asparagine 843 to Serine change. Each bar represents four separate independent 
enzymatic assays.
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upstream 3′ splice site and a downstream transcriptional termination sequence with a poly(A) tail was inserted as 
a reporter allele while exon 14 was removed (Fig. 4A). This mouse carried a truncated Ppip5k2 protein containing 
the full kinase domain and a truncated (limited to the first 82 residues) phosphatase domain, which eliminates 
phosphatase activity and increases kinase activity42. The allele has previously been designated as Ppip5k2K^ to 
emphasize its elevated kinase activity42. We used the littermate wild-types as our controls. The colony was main-
tained by crossing Ppip5k2+/K^ to Ppip5k2+/K^ or Ppip5k2+/K^ to Ppip5k2+/+. This age of 3-month was chosen 
because murine corneal epithelium and corneal stroma thickness stabilize after 2 months of age45. In addition, 
this age is equivalent to the prevalent teenage onset of KC in human patients46.
We used Spectral Domain Optical Coherence Tomography (SD-OCT) scanning, histological staining, and 
slit lamp bio-microscopy to visualize the anterior segment, including the cornea. We observed irregularities on 
the anterior corneal surface in the Ppip5k2+/K^ (Fig. 4C) and Ppip5k2K^/K^ (Fig. 4D) mice at three months of age 
compared to their littermate Ppip5k2+/+ controls (Fig. 4B). Approximately 40% of the Ppip5k2+/K^ and Ppip5k2K^/
K^ mice showed significantly corneal surface irregularities of the anterior surface (Fig. 5A), indicating potential 
incomplete penetrance, similar to that of KC in human patients. Central cornea thickness (CCT) measurements 
did not change significantly across the three different genotypes (Fig. 5B), while the anterior chamber depth was 
significantly reduced in the Ppip5k2K^/K^ mice (Fig. 5C). H&E (Hematoxylin & Eosin) staining of mouse corneal 
sections revealed that these surface irregularities primarily manifested as thickened epithelium (Fig. 6). Slit lamp 
examination revealed corneal opacity of mouse corneas in the Ppip5k2+/K^ and Ppip5k2K^/K^ mice (Fig. 7).
Figure 3. PPIP5K2 expression in corneal cells and tissue. (A) Human corneal epithelial cells (HCEC) and 
human corneal stromal fibroblasts (HCSF) (n = 3) showed higher expression of PPIP5K2 transcripts than 
PPIP5K1. (B) PPIP5K1 (green) and (C) PPIP5K2 (green) protein expression in human cornea. (D) PPIP5K1 
(green) and (E) PPIP5K2 (green) protein expression in mouse cornea. (F) PPIP5K1 and (G) PPIP5K2 protein 
expression in mouse retina. Error bars represent standard error of the mean. Green fluorescence represents 
the target protein, blue fluorescence represents DAPI (4′,6-diamidino-2-phenylindole). Abbreviations: Ep for 
epithelium, St for stroma, End for endothelium, RPE for retinal pigment epithelium, OS for outer segment, IS 
for inner segment, ONL for outer nuclear layer, INL for inner nuclear layer, and GCL for ganglion cell layer.
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Corneal topography/tomography and pachymetry mapping have been integrated into the clinical examination 
and diagnosis of human KC patients. However, a similar approach in mouse corneas was not implemented prior 
to this current study. We used calibrated mouse corneal OCT scans and generated mouse cornea tomography 
and pachymetry maps of Ppip5k2+/+ (n = 3), Ppip5k2+/K^ (n = 4), and Ppip5k2K^/K^ (n = 3) mice at 3-month of 
age (Fig. 8). OCT-derived pachymetry mapping exhibited significant diffuse corneal thinning in the Ppip5k2+/K^ 
(Fig. 8d–g) and Ppip5k2K^/K^ mice (Fig. 8h–j) versus their littermate Ppip5k2+/+ controls (Fig. 8a–c). The anterior 
curvature map of mouse corneas (Epithelial Axial Map) showed localized curvature perturbations in the mutant 
mice (Fig. 8). The irregularities of the mouse anterior corneal surface and localized abnormal corneal thinning in 
the Ppip5k2+/K^ and Ppip5k2K^/K^ mice clearly indicate the critical role of Ppip5k2 in maintaining the physiologi-
cal function of the mouse cornea, consistent with the potentially important role of PPIP5K2 in the pathogenesis 
of KC in human patients. However, the slightly more shallow anterior chamber in the Ppip5k2K^/K^ mice was 
unexpected, since in humans KC has frequently been associated with a deeper anterior chamber47–49. On the other 
hand, deeper anterior chamber depth by itself has limited clinical utility in screening for KC50.
Figure 4. Development and Optical Coherence Tomography characterization of the Ppip5k2 gene-trap mouse 
model. (A) Allele map and design of the Ppip5k2K^/K^ mouse model; (B–D) SD-OCT images of the anterior 
chamber of the eye. (B) a Ppip5k2+/+ wild-type mouse; (C) a Ppip5k2+/K^ heterozygous mouse; (D) a Ppip5k2K^/K^  
homozygous mouse. The white arrows indicate the presence of irregular anterior surface in the cornea.
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Visual function changes in Ppip5k2+/K^ & Ppip5k2K^/K^ mouse model. Assessment of visual function 
using the OptoMotry system to evaluate the mouse optokinetic response did not show any significant differences 
in the visual acuity of wild-type Ppip5k2+/+ (n = 7), Ppip5k2+/K^ (n = 5), or Ppip5k2K^/K^ (n = 3) mice (data not 
shown). Contrast sensitivity of the wild-type mice was 8.5 which was higher than the values of 4.4 and 3.6 for the 
Ppip5k2+/K^ and Ppip5k2K^/K^ mice, respectively (data not shown). However, these differences were not statisti-
cally significant.
Discussion
We have successfully identified two novel potentially pathogenic variants in the phosphatase domain of the 
PPIP5K2 gene in two autosomal dominant multiplex KC families. Variant S419A is identified in a four-generation 
US family with European ancestry, and variant N843S is present in an unrelated two-generation family with 
European ancestry. Our in vitro studies indicate the N843S variant separately decreases InsP8 phosphatase activ-
ity and elevates InsP7 kinase activity (Fig. 2), likely resulting in a synergistic activation of InsP8 synthesis in 
vivo40,43. This is the first study to suggest the role of PPIP5K2 coding variants in the genetic etiology of keratoco-
nus. Our mouse model with no phosphatase and hyperkinase activity of Ppip5k2 recapitulates the impact of ele-
vated InsP8 synthesis in vivo42 and, moreover, demonstrated abnormal localized corneal curvature and thinning, 
Figure 5. SD-OCT-based mouse corneal measurements in three different mouse groups: Ppip5k2+/+ wild-type, 
Ppip5k2+/K^ heterozygous, and Ppip5k2K^/K^ homozygous mice. (A) Percentage of mice with irregular anterior 
corneal surfaces found with SD-OCT scanning among the three different groups. (B) Central corneal thickness 
(CCT) measurements among three groups. (C) Anterior chamber depth (ACD) among three groups. (D) SD-
OCT image of a Ppip5k2+/+ mouse representing the method to calculate CCT and ACD.
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as well as epithelial histological changes. Our study is the first to successfully apply OCT-based corneal tomog-
raphy and pachymetry mapping in mouse models to study its relationship with KC. The animal model could be 
used to further characterize the pathogenesis of KC in the future.
PPIP5K2 and its products (InsP7 and InsP8) play a vital role in the inositol phosphate signaling pathway via 
regulation of energy homeostasis, phosphate (Pi) sensing, and immune responses38,51,52.
PPIP5K2 and its paralog PPIP5K1 encode dual functional enzymes which each contain separate kinase and 
phosphatase domains. The kinase activity converts 5-InsP7 to 1,5-InsP8 while the phosphatase dephosphorylates 
1,5-InsP8 to 5-InsP7. To investigate the relative expression of PPIP5K1 and PPIP5K2 in the cornea, we meas-
ured their mRNA and protein levels in human corneal cells and tissues. Our data showed a significantly higher 
expression level of PPIP5K2 in HCEC and HCSF than PPIP5K1. Moreover, immunohistochemistry of human 
and mouse cornea demonstrated a higher expression of PPIP5K2 than PPIP5K1. These data reveal that PPIP5K2 
is the dominant enzyme in the cornea suggesting an important role of this enzyme in the cornea. Interestingly, 
PPIP5K1 demonstrated a markedly high level of expression in the mouse retina indicating a potential specific 
function of PPIP5K1 in this particular tissue.
To study the impact of the identified pathogenic variants on the PPIP5K2 catalytic activity, we introduced 
the point mutations in plasmid constructs encoding the enzyme and a FLAG epitope tag; these constructs were 
transiently transfected into HEK293 cells, and then the recombinant proteins were purified and assayed for both 
kinase and phosphatase activities. Interestingly, the p.Asn843Ser point mutation reduced phosphatase activity 
and increased kinase activity. These two separate but complementary effects of the N843S variant (inhibition of 
phosphatase and activation of kinase) can be expected to produce a synergistic enhancement of InsP8 synthesis 
in vivo40,43. On the other hand, the p.Ser419Ala mutation did not show a significant disturbance in PPIP5K2 enzy-
matic activity. Other regulatory factors might influence the effect of the p.Ser419Ala mutation such as inorganic 
phosphate and glucose, or binding partners40, but we have not yet studied this possibility.
Figure 6. H&E staining of the mouse corneas. Normal epithelium was observed in wild-type Ppip5k2+/+ 
littermate controls (A,B). Thickened corneal epithelium layer was observed in some Ppip5k2+/K^ heterozygous 
(C) and Ppip5k2K^/K^ homozygous (E) mouse corneas. These corneas (C,E) were found to have irregular 
anterior corneal surfaces using SD-OCT scanning. Normal corneal epithelium thickness was noticed in other 
Ppip5k2+/K^ heterozygous (D) and Ppip5k2K^/K^ homozygous (F) mouse corneas. These corneas (D,F) were 
found to have no irregular anterior corneal surfaces using OCT scanning at 3 months of age. The black arrows 
showed the thickened epithelium in panels C and E. Abbreviations: Ep for epithelium, St for stroma, and End 
for endothelium of the mouse cornea.
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The impact of N843S variant in vitro (a decreased phosphatase activity and a separate activation of kinase 
activity) is reminiscent of a previous study42, that described the impact of an R837H variant of PPIP5K2. Both 
R837 and N843 could influence phosphatase activity by virtue of being only slightly C-terminal to His828 
(which is part of the catalytic H[D/I/V/A] dipeptide)53. The influence of the N843S and R837H variants upon the 
PPIP5K2 kinase activity, which resides in a separate domain, would presumably involve some form of long-range 
allosteric coupling.
The availability of multiple inbred mouse strains and their physiological similarity to humans make mouse 
models attractive to study human genetic disorders54. Accordingly, to recapitulate genetically-based increased 
InsP8 synthesis in vivo, we used a Ppip5k2 gene trapped ‘hyperkinase’ mouse model with beta-galactosidase 
containing cassette to replace exon 14. We examined the cornea anterior curvature from three groups of mice: 
Ppip5k2+/K^, Ppip5k2K^/K^ and their littermate wild type Ppip5k2+/+ controls at 3–4 months of age.
An important feature of our study has been to enhance the human-health significance of our findings, by 
application of diagnostic tools routinely used for diagnosis of corneal abnormalities by corneal specialists such 
as SD-OCT, slit lamp, and corneal histology to assess mouse corneal structural changes. Slit lamp examina-
tion revealed varying degrees of corneal opacification and a shallow anterior chamber in the Ppip5k2+/K^ and 
Ppip5k2K^/K^ mice versus their littermate controls. A slight reduction in anterior chamber depth was also observed 
by SD-OCT, albeit only in the Ppip5k2K^/K^ mice. Interestingly, human KC patients often have a deeper anterior 
chamber47–49. In that sense, our data mirror some concerns in the literature of the clinical utility of anterior 
chamber depth in screening for KC50. However, we do note the relatively small sample size of the homozygous 
Ppip5k2K^/K^ mice (Fig. 5C).
Among the three different groups (wild type, Ppip5k2+/K^, and Ppip5k2K^/K^), approximately 40% of the 
mutant mice exhibited the abnormal anterior corneal curvature, indicating incomplete penetrance. High qual-
ity OCT-based anterior curvature and thickness mapping clearly indicates abnormally thin localized corneal 
regions in the Ppip5k2+/K^ mice, whereas the Ppip5k2K^/K^ mice presented with more diffuse corneal changes. 
Nevertheless, our study is the first to successfully apply OCT-based corneal tomography and pachymetry map-
ping in mouse models to study its relationship with KC. Additional histological staining showed pronounced 
epithelial abnormalities.
The corneal opacities, abnormal cornea structure and surface irregularities observed in the Ppip5k2+/K^ and 
Ppip5k2K^/K^ mice have the potential to impair visual function by interfering with the amount of light reaching the 
retina. For Ppip5k2+/K^ and Ppip5k2K^/K^ mice visual acuity measured as the spatial frequency threshold at 100% 
contrast was similar to wild-type mice. The Ppip5k2+/K^ and Ppip5k2K^/K^ mutant mice did, however, have reduced 
contrast sensitivity compared to wild-type mice. Corneal abnormalities may well mimic conditions such as low 
light or glare which can reduce the mouse’s ability to detect differences in contrast.
In addition to the pathogenic variants in the PPIP5K2 gene, WGS revealed an intronic variant within the 
PCSK1 gene (rs373951075, c.1096-10 G > A) in the four-generation family. This variant is located in the narrow 
region identified by both linkage and association analysis of this specific family with complete segregation of 
KC haplotype. Interestingly, heterozygous Ppip5k2+/K^ mice (Fig. 8) showed localized corneal thinning patterns 
resembling KC-associated clinical phenotype while homozygous Ppip5k2K^/K^ mice had a more progressed dif-
fuse pattern of corneal thinning resembling that of keratoglobus-related phenotype. These different phenotypes 
Figure 7. Slit lamp biomicroscopic examination of mouse cornea. Images of mouse cornea at 3 months of age 
with wild type Ppip5k2+/+ (A), heterozygous Ppip5k2+/K^ (B), and homozygous Ppip5k2K^/K^ mice (C).
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suggest that other genetic factors such as the intronic variant in PCSK1 may work together with PPIP5K2 to cause 
specific clinical features associated with KC.
Based on our bioinformatics analysis, this variant of PCSK1 is located in a consensus sequence that binds 
with JunD, an AP-1 transcription factor subunit. The consensus sequence includes a cAMP-responsive element 
(CRE) motif to which JunD binds and forms heterodimers with the ATF (activating transcription factor) family 
Figure 8. Mouse corneal curvature and corneal thickness mapping. The uppercase letter represents curvature 
map (epithelial axial map), while the lowercase letter represents the thickness map (pachymetry). Panels (A–C), 
(a–c) for wild-type Ppip5k2+/+ mice, (D–G), (d–g) for the Ppip5k2+/K^ mice, and (H–J), (h–j) for the Ppip5k2K^/
K^ mice. All mice were at 3–4 months of age. The focally abnormal thin cornea regions were marked with black 
arrows.
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members55,56. JunD acts as a transcriptional activator or repressor of specific target genes to regulate diverse vital 
processes including cellular proliferation, differentiation and oxidative stress57. Sequence change at this specific 
location may lead to altered JunD binding and thus potentially affect the hormone processing activity of PCSK1. 
Recent studies have suggested the potential role of hormone-related factors such as prolactin and 17β-estradiol in 
the pathogenesis of KC13,46,58–60. It may also be interesting to study the potential interaction of this intronic variant 
and PPIP5K2 coding variants in the future.
It may also be relevant that PPIP5K2 is a predicted target gene of transcription factor PRDM5 (PR/SET 
Domain 5) through ChIP-Seq (chromatin immunoprecipitation sequencing) experiment61. Homozygous muta-
tions of PRDM5 have been identified in human patients with brittle cornea syndrome61–64. PRDM5 mutations are 
considered a strong predisposing factor for the development of KC in several families64. It will be important to 
confirm the potential functional connection between PRDM5 and PPIP5K2 in human and mouse corneas.
It has been recognized that genetic susceptibility to KC could be modified by environmental, hormo-
nal, and biomechanical factors as well as inflammation factors13,65. In spite of the large number of identified 
linkage loci, genetic mutations have been reported in only a limited number of genes including MIR184 and 
DOCK97,18,27,29,30,32,66. This could be due to complex inheritance patterns such as digenic inheritance67. The pen-
etrance of genetic mutations could be affected by mechanical/environmental factors such as eye rubbing, UV 
exposure, atopic conditions, and the sensitivity of clinical detection of sub-clinical corneal phenotypes in patients, 
as well3,7,65. The incomplete penetrance and co-segregation of genetic mutations have been noted in our familial 
study. Therefore, in vitro and in vivo functional studies are critical to characterize the identified mutations.
In conclusion, we have identified two novel variants located in the phosphatase domain of the PPIP5K2 gene 
in two US families with familial KC and one potentially functional variant in the PCSK1 gene. Our in vitro cata-
lytic assays and in vivo mouse model strongly suggest a role for PPIP5K2 in the pathogenesis of KC. It is the first 
time to integrate mouse corneal tomography and pachymetry mapping in mouse corneal phenotyping. However, 
further studies will be valuable to investigate the exact effect of the identified variants in the cornea. This could be 
accomplished by using a CRISPR-mediated knock-in mouse model for the identified variants.
Methods
Human subjects and DNA Isolation. The Institutional Review Board at the Cedars Sinai Medical Center 
approved the research protocol. All patients and family members were informed about the study and consented 
using written informed consent. DNA was extracted from Epstein-Barr virus (EBV) - transformed lymphoblast 
cells of all family members using Puregene kit24,37. DNA Samples >10 kb in size with no or little degradation 
were selected for WES and WGS. All methods were performed in accordance with the relevant guidelines and 
regulations.
Whole exome and whole genome sequencing. For WES, fourteen high quality DNA samples were 
enriched with Roche NimbleGen SeqCap EZ Exome Library v3.0 followed up by 100 bp paired-end sequenc-
ing as previously described41. The bioinformatics analysis was performed by the Bioinformatics Core at Duke 
University Medical Center as previously described41. Briefly, sequencing reads were aligned to human reference 
genome NCBI build 37 with the BWA (Burrows-Wheeler Alignment) algorithm68. Potential PCR duplicate reads 
were removed with Picard and variants were called with GATK (Genome Analysis Tool Kit), following the Broad 
Institute’s Best Practices Workflow69–71. The called variants were annotated for their functional impact using 
SnpEff (SNP effect) with annotations from Ensembl72. All the DNA samples were sequenced with at least 75x 
average coverage for all targeted regions.
Five individual DNA samples were selected for additional WGS analysis (Fig. 1A) with paired-end 150 bp 
sequencing using Illumina HiSeq XTEN sequencer with >30X average coverage at New York Genome Center 
(NYGC). Bioinformatics analysis was performed using the standard automated high-performance pipeline 
at NYGC. Reads were aligned to the GRCh37 human reference genome using the Burrows-Wheeler Aligner 
(BWA-MEM v0.78)68 and processed using the best-practices pipeline that includes marking of duplicate reads 
by using Picard, realignment around indels, and base recalibration via GATK v3.2.270. To improve variant call 
accuracy, five single-sample GVCF files were jointly genotyped using GATK GenotypeGVCFs to generate 
a multi-sample VCF (variant call format) file. Variant annotations were done using SnpEff72, VCFtools73, and 
NYGC in-house custom software.
Sequence variant filtering pipeline. We applied a specific sequence analysis pipeline in a combination 
with RNA-Seq-based gene expression data from 9 unaffected human corneas to filter and prioritize all the vari-
ants (Supplemental Fig. 4). We used the SNP & Variation Suite (SVS) version 8.0 software from Golden Helix for 
our analysis. We filtered the variants using the following criteria: 1) good sequencing quality and high read depth 
(>10–20); 2) absence in the unaffected controls without linkage haplotype; 3) MAF ≤ 0.01 in publicly available 
variant databases (The Exome Aggregation Consortium (ExAC), NHLBI GO Exome Sequencing Project (ESP), 
Genome Aggregation Database (gnomAD), and 1000 Genomes); 4) coding non-synonymous variants; 5) hete-
rozygous in the affected patients; 6) located in genes with expression in human cornea; and 7) located within/
adjacent the linkage locus chr5q14.3–21.1. We applied a similar filtering pipeline for the WGS data to prioritize 
the variants (Supplemental Fig. 5).
In vitro functional assays for PPIP5K2. Plasmids hosting human PPIP5K2 (NM_001345875) were 
constructed as previously described39,40. Individual variants S419A or N843S were constructed using the Q5 
site-directed mutagenesis kit (New England Biolabs). The paired primers were designed as follows (muta-
genic nucleotide is lower case): S419A forward: TGGATATAAAgCAGGGAAATTAAAAC, and the reverse: 
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TCACACTTTTCAAAAAGATCAAAAAATTTC; N843S forward: GCCTTATGCAgTGAATCAAAG, and 
the reverse: ACCATAGCGAAGAATAGAC. HEK293 cells were transiently transfected with plasmids con-
taining FLAG-tagged PPIP5K2, PPIP5K2 (p.S419A) or PPIP5K2 (p.N843S) using Lipofectamine 3000 (Life 
Technologies). Cells were harvested and lysed 16–20 hours after transfection. The FLAG-tagged PPIP5K2 pro-
teins were immunopurified using FLAG M2 affinity gel (MilliporeSigma) and analyzed by SDS-PAGE and stained 
with Coomassie Blue.
The enzymatic assays of PPIP5K2 phosphatase and kinase activities were performed as previously described39. 
Briefly, PPIP5K2 phosphatase activities were measured at 37 °C for 30 min incubations. The activities were calcu-
lated by how much InsP8 hydrolyzed to 5-InsP7, which was quantified by HPLC. Kinase activities were measured 
at 37 °C for 1 h incubations. The reaction was quenched and the conversion of 5-InsP7 to InsP8 was determined 
by HPLC.
Culture of primary human corneal epithelial cells and stromal fibroblasts. Human donor eyes 
were received from the Georgia Eye Bank (Atlanta, GA, USA) within 24 hours after death. Primary HCEC and 
HCSF were isolated from the donors’ eyes according to the established protocols74,75. HCEC were cultured in high 
glucose DMEM (Dulbecco’s modified eagle medium, Gibco), 10 ng/mL human recombinant EGF (epidermal 
growth factor), 10% fetal bovine serum, 1% insulin-transferrin-selenium-100× (Gibco), and 40 µg/mL gentamy-
cin (Sigma). The HCSF were cultured similarly as HCEC but without human recombinant EGF.
PPIP5K1 and PPIP5K2 expression with ddPCR. Specific EvaGreen-based ddPCR assays for PPIP5K1 
(dHsaEG5000994) and PPIP5K2 (dHsaEG5018506) were obtained from Bio-Rad Laboratories, Inc., to measure 
the expression of PPIP5K1 and PPIP5K2 in primary HCEC and HCSF as previously described76,77. We integrated 
two internal reference genes (GAPDH - glyceraldehyde 3-phosphate dehydrogenase and HPRT1 - hypoxanthine 
phosphoribosyltransferase 1) to be quantified in the samples for normalization purpose. Both showed similar 
consistent expression among all samples. For figure purposes we normalized with HPRT178.
Mouse husbandry. We obtained breeding pairs of heterozygous B6N (Cg)-Ppip5k2tm1b (EUCOMM)Wtsi/J mice 
from the Jackson Laboratory (Fig. 4A) (Bar Harbor, ME). This mouse model has no phosphatase activity, but 
elevated kinase activity (designated as Ppip5k2K^)42. A beta-galactosidase containing cassette with an upstream 3′ 
splice site and a downstream transcriptional termination sequence with a poly(A) tail was inserted as a reporter 
allele to replace exon 14. Mice were bred and maintained according to the guidelines described in the Association 
for Research in Vision and Ophthalmology Statement for the Use of Animals in Vision and Ophthalmic Research 
and the Augusta University animal handling guidelines. The mouse protocol was approved by the Institutional 
Animal Care and Use Committee (IACUC) at Augusta University. Following the Jackson Laboratory protocol, 
mouse genotype was assessed using PCR with the recommended conditions.
In vivo mouse eye examination. For slit lamp and SD-OCT examination live mice were anesthetized 
using a rodent anesthesia cocktail as previously described79–81. GenTeal Lubricant Eye Gel (Alcon, Ft. Worth, TX, 
USA) was applied after anesthesia until the examination started. Systane lubricant eye drops from Alcon were 
applied throughout the eye examination to avoid cornea dryness.
The cornea and anterior chamber of anesthetized mouse were examined with a slit lamp (SL-D7; Topcon, 
Tokyo, Japan), and images were documented with a digital camera (D100; Nikon, Tokyo, Japan). We also used 
SD-OCT to visualize the anterior segments in mice45,82. The anterior chamber structure and corneal curvature 
of the anesthetized mice were examined using Bioptigen Spectral-Domain Ophthalmic Imaging System (Envisu 
R2200; Bioptigen)83. Briefly, we used a 12 mm telecentric probe and set the reference arm at position 245. Three 
scans were performed for each eye, producing one rectangular and two radial scans. The central corneal thickness 
and the anterior depth were assessed using the default DIVERS software (Fig. 4D).
Corneal curvature and corneal thickness mapping. Corneal biometric parameters including corneal 
curvature, topography, and pachymetry were measured from the corneal OCT images using methods previously 
described for human corneal OCT images adapted for mouse corneal OCT images84,85.
From the corneal surface data, pachymetry (corneal thickness) maps were created by direct z-axis subtraction 
of the epithelial and endothelial layers. Curvature maps were created by calculating local epithelial curvatures 
based on formulas outlined in the ANSI Z80.23-2007 standards for human corneal topography86. Instantaneous 
curvatures were calculated along meridians across the nominal optical zone. A radius of curvature (Rc) to 
describe the average curvature of each specific cornea was calculated by fitting the anterior corneal surface to a 
sphere using least squares fitting.
Histology and immunohistochemistry in human and mouse corneas. Postmortem human corneas 
were obtained from North Carolina Eye Bank. Whole mouse eyes were removed immediately after euthanizing 
the animals. Human cornea or mouse eyes were fixed in Davidson’s fixative for <24hrs, transferred to 70% etha-
nol. Mouse corneas were processed for H&E staining at the AU Electron Microscopy and Histology Core. Human 
corneas were processed at the Georgia Esoteric and Molecular (GEM) Laboratory for H&E staining.
For immunohistochemistry, mouse or human cornea sections were rehydrated and incubated with rabbit 
anti-PPIP5K2 (Abcam, ab204374, 1:100), or anti-PPIP5K1 (Sigma, HPA039380, 1:100) primary antibody at 
4 °C overnight. Slides were incubated with the secondary antibody (Alexa fluor 488 conjugated goat anti-rabbit, 
Invitrogen) for 1 hr. Slides were imaged with a Zeiss Axio Imager D2 microscope equipped with a high-resolution 
camera and Zeiss Zen23pro software.
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Assessment of visual function. Visual function in wild-type Ppip5k2+/+ (n = 7), Ppip5k2+/K^ (n = 5), and 
Ppip5k2K^/K^ (n = 3) mice was determined using the OptoMotry system (CerebralMechanics, Inc.)87,88. Visual 
acuity and contrast sensitivity are measured via rapid quantification of opto-kinetic tracking (OKT) thresholds 
as previously described79. Visual acuity was determined as the highest spatial frequency for which mice tracked 
a 100% contrast sine wave grating. Contrast sensitivity was identified as 100 divided by the minimum percent 
contrast that generated tracking at a spatial frequency of 0.064 cycles/degree. This value for spatial frequency 
is known to produce a robust tracking response and substantial contrast sensitivity88. All measurements were 
taken at a constant grating speed of 12 degrees/second. Measurements were performed by an investigator (BAM) 
blinded to mouse genotypes.
Statistical analysis. Statistical significance was calculated using the two-tailed Student’s t-test with 
GraphPad Prism 8.02. A p value ≤ 0.05 was considered statistically significant.
Data availability
The WES and WGS datasets supporting the conclusions of this article, due to the limits stipulated in the original 
informed consent forms, could not be deposited into the dbGAP (the database of genotypes and phenotypes) 
or other public databases. The de-identified WES and WGS sequencing data may be available to qualified 
investigators upon request made to the Research Institutional Review Board at Augusta University by submitting 
to irb@augusta.edu. The gene-trap mice were purchased from the Jackson Laboratory and were available at the 
KOMP (the Knockout Mouse Project) Repository at the University of California, Davis. These mice are also 
available upon request made to the corresponding author.
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